TAVR Without Predilatation (TAVIWOP)

University Hospital Center (CHU)

Status: Unknown

Conditions: Aortic Stenosis

Treatments: Procedure: Transcatheter aortic valve implantation required for symptomatic aortic stenosis

Study type: Observational

Funder types: Other

Identifiers

NCT04350658

RECHMPL20_0204

Details and patient eligibility

About

The procedure is performed via transfemoral or transcaprotid access; Patients were confirmed to be eligible for TAVR by a multidisciplinary heart team including at least an interventional cardiologist, a cardiothoracic surgeon and an anesthetist. All TAVR implantation procedures were performed with the Edwards SAPIEN 3 THV or the MEDTRONIC CoreValve EVOLUT . For all patients, both vascular access and aortic valve were evaluated before the procedure by multislice computerized tomographic angiography (MSCT) of the entire aorta using vascular windows settings. The prosthesis and the vascular access were left to the discretion of the operating team. Transfemoral access was the first choice when possible. All TAVR procedures were performed in the same hybrid room (in Montpellier University Hospital), Most TAVR were performed under sedation or general anesthesia using mild low profile 14-16 French delivery systems and using percutaneous or surgical vascular access.

Enrollment: 138 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients undergoing TAVR via transfemoral or rascoarotid access

Exclusion criteria

• others access (subclavian, apical, transaortic)

Trial design

138 participants in 1 patient group

TAVR

Description:

all comers study including all transfemoral or transcarotid TAVR procédures. direct implantation is the default strategy usually used in our enter as in may centers

Treatment:

Procedure: Transcatheter aortic valve implantation required for symptomatic aortic stenosis